“Patients are absolutely firmly at the centre. That every day we get out of bed, with the patient and their caregivers and families, front of mind. […] You can't be successful in drug development and novel therapeutic development, without engaging the patient communities, as a partner and as a collaborator on the journey.”
In this week’s episode of The G Word, our CEO Chris Wigley is joined by Dr Annalisa Jenkins, non-Executive Director at Perspectrum Ltd, Oncimmune, AVROBIO, Affimed, COMPASS Pathways and Genomics England
They discuss Annalisa’s background across life sciences and the role of genomics in development of diagnostics and therapeutics. They also discuss the importance of patient communities.
